MV100052: Tris-GalNAc-PEG5-NHS Ester Pack Size:1 mg Anticoagulant / Dabigatran-d4 / N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine-d4

Anticoagulant / Dabigatran-d4 / N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine-d4

C17H30O13 / 442

C22H29NO9 / 451

5-Diamino-2-(6-carboxy-3

1-[2-[4-(2

MV100052: Tris-GalNAc-PEG5-NHS Ester Pack Size:1 mg Anticoagulant / Dabigatran-d4 / N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine-d4C79H137N11O37 1832. 98 A triantennary N acetylgalactosamine (Tri GalNAc) ligand presenting three GalNAc residues on a tris based branched scaffold, equipped with an N hydroxysuccinimide (NHS) activated ester through a discrete, monodisperse pentaethylene glycol (PEG5) spacer. The NHS ester reacts with primary amines to form stable amide bonds, providing a single step route to conjugate the Tri GalNAc ligand onto amine bearing payloads, antibodies,